Glycerol 3-phosphate dehydrogenases (1 and 2) in cancer and other diseases.
Journal
Experimental & molecular medicine
ISSN: 2092-6413
Titre abrégé: Exp Mol Med
Pays: United States
ID NLM: 9607880
Informations de publication
Date de publication:
01 May 2024
01 May 2024
Historique:
received:
31
08
2023
accepted:
18
02
2024
revised:
05
02
2024
medline:
1
5
2024
pubmed:
1
5
2024
entrez:
30
4
2024
Statut:
aheadofprint
Résumé
The glycerol 3-phosphate shuttle (GPS) is composed of two different enzymes: cytosolic NAD
Identifiants
pubmed: 38689091
doi: 10.1038/s12276-024-01222-1
pii: 10.1038/s12276-024-01222-1
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministry of Science, ICT and Future Planning (MSIP)
ID : NRF-2018R1A3B1052328
Informations de copyright
© 2024. The Author(s).
Références
Meyerhof, O. Über die Atmung der Froschmuskulatur. Pflug. Arch. Gesamt. Physiol. Menschen Tiere 175, 20–87 (1919).
doi: 10.1007/BF01722140
Estabrook, R. W. & Sacktor, B. α-glycerophosphate oxidase of flight muscle mitochondria. J. Biol. Chem. 233, 1014–1019 (1958).
pubmed: 13587533
doi: 10.1016/S0021-9258(18)64696-4
Sacktor, B. & Dick, A. Pathways of hydrogen transport in the oxidation of extramitochondrial reduced diphosphopyridine nucleotide in flight muscle. J. Biol. Chem. 237, 3259–3263 (1962).
pubmed: 13975951
doi: 10.1016/S0021-9258(18)50156-3
Borst, P. The malate-aspartate shuttle (Borst cycle): how it started and developed into a major metabolic pathway. IUBMB Life 72, 2241–2259 (2020).
pubmed: 32916028
pmcid: 7693074
doi: 10.1002/iub.2367
Klingenberg, M. Localization of the glycerol-phosphate dehydrogenase in the outer phase of the mitochondrial inner membrane. Eur. J. Biochem 13, 247–252 (1970).
pubmed: 5439930
doi: 10.1111/j.1432-1033.1970.tb00924.x
Boxer, G. E. & Shonk, C. E. Low levels of Soluble DPN-linked α-glycerophosphate dehydrogenase in tumors*. Cancer Res. 20, 85–91 (1960).
pubmed: 13803504
Ohkawa, K. I., Vogt, M. T. & Farber, E. Unusually high mitochondrial alpha glycerophosphate dehydrogenase activity in rat brown adipose tissue. J. Cell Biol. 41, 441–449 (1969).
pubmed: 5783866
pmcid: 2107766
doi: 10.1083/jcb.41.2.441
Houstĕk, J., Cannon, B. & Lindberg, O. Gylcerol-3-phosphate shuttle and its function in intermediary metabolism of hamster brown-adipose tissue. Eur. J. Biochem. 54, 11–18 (1975).
pubmed: 168075
doi: 10.1111/j.1432-1033.1975.tb04107.x
Greenhouse, W. V. & Lehninger, A. L. Occurrence of the malate-aspartate shuttle in various tumor types. Cancer Res. 36, 1392–1396 (1976).
pubmed: 177206
Greenhouse, W. V. & Lehninger, A. L. Magnitude of malate-aspartate reduced nicotinamide adenine dinucleotide shuttle activity in intact respiring tumor cells. Cancer Res. 37, 4173–4181 (1977).
pubmed: 198130
Brown, L. J., Koza, R. A., Marshall, L., Kozak, L. P. & MacDonald, M. J. Lethal hypoglycemic ketosis and glyceroluria in mice lacking both the mitochondrial and the cytosolic glycerol phosphate dehydrogenases. J. Biol. Chem. 277, 32899–32904 (2002).
pubmed: 12093800
doi: 10.1074/jbc.M202409200
Mráček, T., Drahota, Z. & Houštěk, J. The function and the role of the mitochondrial glycerol-3-phosphate dehydrogenase in mammalian tissues. Biochim. Biophys. Acta 1827, 401–410 (2013).
pubmed: 23220394
doi: 10.1016/j.bbabio.2012.11.014
Ou, X. et al. Crystal structures of human glycerol 3-phosphate dehydrogenase 1 (GPD1). J. Mol. Biol. 357, 858–869 (2006).
pubmed: 16460752
doi: 10.1016/j.jmb.2005.12.074
Patsouris, D. et al. PPARalpha governs glycerol metabolism. J. Clin. Investig. 114, 94–103 (2004).
pubmed: 15232616
pmcid: 437964
doi: 10.1172/JCI200420468
Bogacka, I., Xie, H., Bray, G. A. & Smith, S. R. The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo. Diabetes Care 27, 1660–1667 (2004).
pubmed: 15220243
doi: 10.2337/diacare.27.7.1660
Chen, K. W., Chen, Y. S., Chen, P. J. & Yeh, S. H. Androgen receptor functions in pericentral hepatocytes to decrease gluconeogenesis and avoid hyperglycemia and obesity in male mice. Metabolism 135, 155269 (2022).
pubmed: 35914621
doi: 10.1016/j.metabol.2022.155269
Liu, R. et al. A HIF1alpha-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism. J. Exp. Clin. Cancer Res. 40, 188 (2021).
pubmed: 34098990
pmcid: 8185942
doi: 10.1186/s13046-021-01996-6
Musri, M. M., Corominola, H., Casamitjana, R., Gomis, R. & Parrizas, M. Histone H3 lysine 4 dimethylation signals the transcriptional competence of the adiponectin promoter in preadipocytes. J. Biol. Chem. 281, 17180–17188 (2006).
pubmed: 16613853
doi: 10.1074/jbc.M601295200
Zhang, S. et al. Identification of potential key genes associated with adipogenesis through integrated analysis of five mouse transcriptome datasets. Int. J. Mol. Sci. 19, 3557 (2018).
pubmed: 30424473
pmcid: 6274731
doi: 10.3390/ijms19113557
Lee, Y. J., Jeschke, G. R., Roelants, F. M., Thorner, J. & Turk, B. E. Reciprocal phosphorylation of yeast glycerol-3-phosphate dehydrogenases in adaptation to distinct types of stress. Mol. Cell Biol. 32, 4705–4717 (2012).
pubmed: 22988299
pmcid: 3486180
doi: 10.1128/MCB.00897-12
Swierczynski, J. et al. Enhanced glycerol 3-phosphate dehydrogenase activity in adipose tissue of obese humans. Mol. Cell Biochem. 254, 55–59 (2003).
pubmed: 14674682
doi: 10.1023/A:1027332523114
Sledzinski, T. et al. Association between cytosolic glycerol 3-phosphate dehydrogenase gene expression in human subcutaneous adipose tissue and BMI. Cell Physiol. Biochem. 32, 300–309 (2013).
pubmed: 23942261
doi: 10.1159/000354438
Park, J. J., Berggren, J. R., Hulver, M. W., Houmard, J. A. & Hoffman, E. P. GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Physiol. Genom. 27, 114–121 (2006).
doi: 10.1152/physiolgenomics.00045.2006
Basel-Vanagaite, L. et al. Transient infantile hypertriglyceridemia, fatty liver, and hepatic fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate dehydrogenase 1. Am. J. Hum. Genet. 90, 49–60 (2012).
pubmed: 22226083
pmcid: 3257852
doi: 10.1016/j.ajhg.2011.11.028
Joshi, M. et al. A compound heterozygous mutation in GPD1 causes hepatomegaly, steatohepatitis, and hypertriglyceridemia. Eur. J. Hum. Genet. 22, 1229–1232 (2014).
pubmed: 24549054
pmcid: 4169545
doi: 10.1038/ejhg.2014.8
Li, J. Q. et al. A novel homozygous mutation in the glycerol-3-phosphate dehydrogenase 1 gene in a Chinese patient with transient infantile hypertriglyceridemia: a case report. BMC Gastroenterol. 18, 96 (2018).
pubmed: 29940878
pmcid: 6020200
doi: 10.1186/s12876-018-0827-6
Lin, H. et al. Case report: identification of a novel homozygous mutation in GPD1 gene of a Chinese child with transient infantile hypertriglyceridemia. Front. Genet. 12, 726116 (2021).
pubmed: 34484308
pmcid: 8416348
doi: 10.3389/fgene.2021.726116
Polchar, L. & Vallabhaneni, P. Case of GPD1 deficiency causing hypertriglyceridaemia and non-alcoholic steatohepatitis. BMJ Case Rep. 15, e246369 (2022).
pubmed: 35450873
doi: 10.1136/bcr-2021-246369
MacDonald, M. J. & Marshall, L. K. Mouse lacking NAD+-linked glycerol phosphate dehydrogenase has normal pancreatic beta cell function but abnormal metabolite pattern in skeletal muscle. Arch. Biochem. Biophys. 384, 143–153 (2000).
pubmed: 11147825
doi: 10.1006/abbi.2000.2107
MacDonald, M. J. & Marshall, L. K. Survey of normal appearing mouse strain which lacks malic enzyme and Nad+-linked glycerol phosphate dehydrogenase: normal pancreatic beta cell function, but abnormal metabolite pattern in skeletal muscle. Mol. Cell Biochem. 220, 117–125 (2001).
pubmed: 11451371
doi: 10.1023/A:1010821821921
Hilgers, J. et al. Genetic differences in BALB/c sublines. Curr. Top. Microbiol. Immunol. 122, 19–30 (1985).
pubmed: 2994956
Prochazka, M., Kozak, U. C. & Kozak, L. P. A glycerol-3-phosphate dehydrogenase null mutant in BALB/cHeA mice. J. Biol. Chem. 264, 4679–4683 (1989).
pubmed: 2466839
doi: 10.1016/S0021-9258(18)83796-6
Sato, T., Morita, A., Mori, N. & Miura, S. Glycerol 3-phosphate dehydrogenase 1 deficiency enhances exercise capacity due to increased lipid oxidation during strenuous exercise. Biochem. Biophys. Res. Commun. 457, 653–658 (2015).
pubmed: 25603051
doi: 10.1016/j.bbrc.2015.01.043
Sato, T., Sayama, N., Inoue, M., Morita, A. & Miura, S. The enhancement of fat oxidation during the active phase and suppression of body weight gain in glycerol-3-phosphate dehydrogenase 1 deficient mice. Biosci. Biotechnol. Biochem. 84, 2367–2373 (2020).
pubmed: 32662756
doi: 10.1080/09168451.2020.1792268
Sato, T. et al. EID1 suppresses lipid accumulation by inhibiting the expression of GPDH in 3T3-L1 preadipocytes. J. Cell Physiol. 235, 6725–6735 (2020).
pubmed: 32056205
doi: 10.1002/jcp.29567
Hwang, K. et al. Alteration of the NAD+/NADH ratio in CHO cells by stable transfection with human cytosolic glycerol-3-phosphate dehydrogenase: resistance to oxidative stress. Mol. Cells 9, 429–435 (1999).
pubmed: 10515608
doi: 10.1016/S1016-8478(23)13564-3
Jeong, D. W., Kim, T. S., Cho, I. T. & Kim, I. Y. Modification of glycolysis affects cell sensitivity to apoptosis induced by oxidative stress and mediated by mitochondria. Biochem. Biophys. Res. Commun. 313, 984–991 (2004).
pubmed: 14706639
doi: 10.1016/j.bbrc.2003.12.033
Liu, S. et al. Glycerol-3-phosphate biosynthesis regenerates cytosolic NAD(+) to alleviate mitochondrial disease. Cell Metab. 33, 1974–1987.e1979 (2021).
pubmed: 34270929
doi: 10.1016/j.cmet.2021.06.013
Feng, Z. E. et al. The prognostic value of glycerol-3-phosphate dehydrogenase 1-like expression in head and neck squamous cell carcinoma. Histopathology 64, 348–355 (2014).
pubmed: 24274692
doi: 10.1111/his.12258
Moras, E. et al. Genetic and molecular mechanisms in brugada syndrome. Cells. 12, 1791 (2023).
pubmed: 37443825
pmcid: 10340412
doi: 10.3390/cells12131791
London, B. et al. Mutation in glycerol-3-phosphate dehydrogenase 1-like gene (GPD1-L) decreases cardiac Na+ current and causes inherited Arrhythmias. Circulation 116, 2260–2268 (2007).
pubmed: 17967977
pmcid: 3150966
doi: 10.1161/CIRCULATIONAHA.107.703330
Van Norstrand, D. W. et al. Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome. Circulation 116, 2253–2259 (2007).
pubmed: 17967976
pmcid: 3332545
doi: 10.1161/CIRCULATIONAHA.107.704627
Valdivia, C. R., Ueda, K., Ackerman, M. J. & Makielski, J. C. GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A. Am. J. Physiol. Heart Circ. 297, H1446–H1452 (2009).
doi: 10.1152/ajpheart.00513.2009
Liu, T. et al. GPD1L inhibits renal cell carcinoma progression by regulating PINK1/Parkin-mediated mitophagy. J. Cell Mol. Med. 27, 2326–2339 (2023).
doi: 10.1111/jcmm.17813
Brown, L. J., MacDonald, M. J., Lehn, D. A. & Moran, S. M. Sequence of rat mitochondrial glycerol-3-phosphate dehydrogenase cDNA. Evidence for EF-hand calcium-binding domains. J. Biol. Chem. 269, 14363–14366 (1994).
pubmed: 8182039
doi: 10.1016/S0021-9258(17)36629-2
Parsonage, D., Luba, J., Mallett, T. C. & Claiborne, A. The soluble alpha-glycerophosphate oxidase from Enterococcus casseliflavus. Sequence homology with the membrane-associated dehydrogenase and kinetic analysis of the recombinant enzyme. J. Biol. Chem. 273, 23812–23822 (1998).
pubmed: 9726992
doi: 10.1074/jbc.273.37.23812
Claiborne, A. Studies on the structure and mechanism of Streptococcus faecium L-alpha-glycerophosphate oxidase. J. Biol. Chem. 261, 14398–14407 (1986).
pubmed: 3771536
doi: 10.1016/S0021-9258(18)66883-8
Yeh, J. I., Chinte, U. & Du, S. Structure of glycerol-3-phosphate dehydrogenase, an essential monotopic membrane enzyme involved in respiration and metabolism. Proc. Natl Acad. Sci. USA 105, 3280–3285 (2008).
pubmed: 18296637
pmcid: 2265192
doi: 10.1073/pnas.0712331105
Pecinová, A. et al. Role of mitochondrial glycerol-3-phosphate dehydrogenase in metabolic adaptations of prostate cancer. Cells. 9 (2020).
Syngkli, S. & Das, B. Purification and characterization of human glycerol 3-phosphate dehydrogenases (mitochondrial and cytosolic) by NAD(+)/NADH redox method. Biochimie 214, 199–215 (2023).
pubmed: 37481063
doi: 10.1016/j.biochi.2023.07.015
Koza, R. A. et al. Sequence and tissue-dependent RNA expression of mouse FAD-linked glycerol-3-phosphate dehydrogenase. Arch. Biochem. Biophys. 336, 97–104 (1996).
pubmed: 8951039
doi: 10.1006/abbi.1996.0536
Weitzel, J. M., Grott, S., Radtke, C., Kutz, S. & Seitz, H. J. Multiple promoters direct the tissue-specific expression of rat mitochondrial glycerol-3-phosphate dehydrogenase. Biol. Chem. 381, 611–614 (2000).
pubmed: 10987368
doi: 10.1515/BC.2000.078
Muller, S. & Seitz, H. J. Cloning of a cDNA for the FAD-linked glycerol-3-phosphate dehydrogenase from rat liver and its regulation by thyroid hormones. Proc. Natl Acad. Sci. USA 91, 10581–10585 (1994).
pubmed: 7937996
pmcid: 45065
doi: 10.1073/pnas.91.22.10581
Weitzel, J. M., Kutz, S., Radtke, C., Grott, S. & Seitz, H. J. Hormonal regulation of multiple promoters of the rat mitochondrial glycerol-3-phosphate dehydrogenase gene: identification of a complex hormone-response element in the ubiquitous promoter B. Eur. J. Biochem. 268, 4095–4103 (2001).
pubmed: 11454004
doi: 10.1046/j.1432-1327.2001.02332.x
Gong, D. W., Bi, S., Weintraub, B. D. & Reitman, M. Rat mitochondrial glycerol-3-phosphate dehydrogenase gene: multiple promoters, high levels in brown adipose tissue, and tissue-specific regulation by thyroid hormone. DNA Cell Biol. 17, 301–309 (1998).
pubmed: 9539110
doi: 10.1089/dna.1998.17.301
Urcelay, E. et al. Cloning and functional characterization of the 5’ regulatory region of the human mitochondrial glycerol-3-phosphate dehydrogenase gene. Lack of 3,5,3’-triiodothyronine responsiveness in adipose tissue. Eur. J. Biochem. 267, 7209–7217 (2000).
pubmed: 11106433
doi: 10.1046/j.1432-1327.2000.01832.x
Singh, A. et al. Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis. J. Clin. Investig. 123, 2921–2934 (2013).
pubmed: 23921124
pmcid: 3696551
doi: 10.1172/JCI66353
MacDonald, M. J. & Brown, L. J. Calcium activation of mitochondrial glycerol phosphate dehydrogenase restudied. Arch. Biochem. Biophys. 326, 79–84 (1996).
pubmed: 8579375
doi: 10.1006/abbi.1996.0049
Fisher, A. B., Scarpa, A., LaNoue, K. F., Bassett, D. & Williamson, J. R. Respiration of rat lung mitochondria and the influence of Ca 2+ on substrate utilization. Biochemistry 12, 1438–1445 (1973).
pubmed: 4348834
doi: 10.1021/bi00731a026
Hansford, R. G. & Chappell, J. B. The effect of Ca2+ on the oxidation of glycerol phosphate by blowfly flight-muscle mitochondria. Biochem. Biophys. Res. Commun. 27, 686–692 (1967).
pubmed: 4964598
doi: 10.1016/S0006-291X(67)80090-1
Dhoundiyal, A., Goeschl, V., Boehm, S., Kubista, H. & Hotka, M. Glycerol-3-phosphate shuttle is a backup system securing metabolic flexibility in neurons. J. Neurosci. 42, 7339–7354 (2022).
pubmed: 35999055
pmcid: 9525167
doi: 10.1523/JNEUROSCI.0193-22.2022
Llorente-Folch, I. et al. The regulation of neuronal mitochondrial metabolism by calcium. J. Physiol. 593, 3447–3462 (2015).
pubmed: 25809592
pmcid: 4560577
doi: 10.1113/JP270254
Denton, R. M. Regulation of mitochondrial dehydrogenases by calcium ions. Biochim. Biophys. Acta 1787, 1309–1316 (2009).
pubmed: 19413950
doi: 10.1016/j.bbabio.2009.01.005
Bukowiecki, L. J. & Lindberg, O. Control of sn-glycerol 3-phosphate oxidation in brown adipose tissue mitochondria by calcium and acyl-CoA. Biochim. Biophys. Acta 348, 115–125 (1974).
pubmed: 4210023
doi: 10.1016/0005-2760(74)90097-6
Rauchova, H. & Drahota, Z. Inhibition of the glycerol 3-phosphate oxidation by free fatty acids. Int. J. Biochem. 16, 243–245 (1984).
pubmed: 6705975
doi: 10.1016/0020-711X(84)90081-8
Amler, E., Rauchova, H., Svobodova, J. & Drahota, Z. Regulation of glycerol 3-phosphate oxidation in mitochondria by changes in membrane microviscosity. FEBS Lett. 206, 1–3 (1986).
pubmed: 3758342
doi: 10.1016/0014-5793(86)81328-X
Nałecz, M. J., Zborowski, J., Famulski, K. S. & Wojtczak, L. Effect of phospholipid composition on the surface potential of liposomes and the activity of enzymes incorporated. Eur. J. Biochem. 112, 75–80 (1980).
pubmed: 6778695
doi: 10.1111/j.1432-1033.1980.tb04988.x
Meng, J., Zhang, C., Wang, D., Zhu, L. & Wang, L. Mitochondrial GCN5L1 regulates cytosolic redox state and hepatic gluconeogenesis via glycerol phosphate shuttle GPD2. Biochem. Biophys. Res. Commun. 621, 1–7 (2022).
pubmed: 35802941
doi: 10.1016/j.bbrc.2022.06.092
Lu, J. et al. Tumor-associated macrophage interleukin-beta promotes glycerol-3-phosphate dehydrogenase activation, glycolysis and tumorigenesis in glioma cells. Cancer Sci. 111, 1979–1990 (2020).
pubmed: 32259365
pmcid: 7293068
doi: 10.1111/cas.14408
Garrib, A. & McMurray, W. C. Purification and characterization of glycerol-3-phosphate dehydrogenase (flavin-linked) from rat liver mitochondria. J. Biol. Chem. 261, 8042–8048 (1986).
pubmed: 3711123
doi: 10.1016/S0021-9258(19)57509-3
Rauchová, H., Beleznai, Z. & Drahota, Z. Effect of chemical modification in situ on L-glycerol-3-phosphate dehydrogenase in brown adipose tissue mitochondria. J. Bioenerg. Biomembr. 20, 623–632 (1988).
pubmed: 3215904
doi: 10.1007/BF00768923
Brown, L. J. et al. Normal thyroid thermogenesis but reduced viability and adiposity in mice lacking the mitochondrial glycerol phosphate dehydrogenase. J. Biol. Chem. 277, 32892–32898 (2002).
pubmed: 12093799
doi: 10.1074/jbc.M202408200
DosSantos, R. A., Alfadda, A., Eto, K., Kadowaki, T. & Silva, J. E. Evidence for a compensated thermogenic defect in transgenic mice lacking the mitochondrial glycerol-3-phosphate dehydrogenase gene. Endocrinology 144, 5469–5479 (2003).
pubmed: 12960027
doi: 10.1210/en.2003-0687
Arsenijevic, D. et al. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat. Genet. 26, 435–439 (2000).
pubmed: 11101840
doi: 10.1038/82565
Gong, D. W. et al. Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. J. Biol. Chem. 275, 16251–16257 (2000).
pubmed: 10748195
doi: 10.1074/jbc.M910177199
Alfadda, A., DosSantos, R. A., Stepanyan, Z., Marrif, H. & Silva, J. E. Mice with deletion of the mitochondrial glycerol-3-phosphate dehydrogenase gene exhibit a thrifty phenotype: effect of gender. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R147–R156 (2004).
pubmed: 15031134
doi: 10.1152/ajpregu.00103.2004
Liu, X. et al. Mitochondrial glycerol 3-phosphate dehydrogenase promotes skeletal muscle regeneration. EMBO Mol. Med. 10, e9390 (2018).
pubmed: 30389681
pmcid: 6284384
doi: 10.15252/emmm.201809390
Zheng, Y. et al. Deficiency of mitochondrial glycerol 3-phosphate dehydrogenase contributes to hepatic steatosis. Hepatology 70, 84–97 (2019).
pubmed: 30653687
doi: 10.1002/hep.30507
MacDonald, M. J., Warner, T. F. & Mertz, R. J. High activity of mitochondrial glycerol phosphate dehydrogenase in insulinomas and carcinoid and other tumors of the amine precursor uptake decarboxylation system. Cancer Res. 50, 7203–7205 (1990).
pubmed: 1977516
MacDonald, M. J. High content of mitochondrial glycerol-3-phosphate dehydrogenase in pancreatic islets and its inhibition by diazoxide. J. Biol. Chem. 256, 8287–8290 (1981).
pubmed: 6790537
doi: 10.1016/S0021-9258(19)68840-X
Meglasson, M. D., Smith, K. M., Nelson, D. & Erecinska, M. alpha-Glycerophosphate shuttle in a clonal beta-cell line. Am. J. Physiol. 256, E173–E178 (1989).
pubmed: 2643340
Ferrer, J. et al. Mitochondrial glycerol-3-phosphate dehydrogenase. Cloning of an alternatively spliced human islet-cell cDNA, tissue distribution, physical mapping, and identification of a polymorphic genetic marker. Diabetes 45, 262–266 (1996).
pubmed: 8549872
doi: 10.2337/diab.45.2.262
Sener, A., Herberg, L. & Malaisse, W. J. FAD-linked glycerophosphate dehydrogenase deficiency in pancreatic islets of mice with hereditary diabetes. FEBS Lett. 316, 224–227 (1993).
pubmed: 8422947
doi: 10.1016/0014-5793(93)81297-D
Eto, K. et al. Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. Science 283, 981–985 (1999).
pubmed: 9974390
doi: 10.1126/science.283.5404.981
Ueda, K. et al. Overexpression of mitochondrial FAD-linked glycerol-3-phosphate dehydrogenase does not correct glucose-stimulated insulin secretion from diabetic GK rat pancreatic islets. Diabetologia 41, 649–653 (1998).
pubmed: 9662045
doi: 10.1007/s001250050963
Ishihara, H. et al. Effect of mitochondrial and/or cytosolic glycerol 3-phosphate dehydrogenase overexpression on glucose-stimulated insulin secretion from MIN6 and HIT cells. Diabetes 45, 1238–1244 (1996).
pubmed: 8772729
doi: 10.2337/diab.45.9.1238
Novials, A. et al. Mutation in the calcium-binding domain of the mitochondrial glycerophosphate dehydrogenase gene in a family of diabetic subjects. Biochem. Biophys. Res. Commun. 231, 570–572 (1997).
pubmed: 9070847
doi: 10.1006/bbrc.1997.6147
Gudayol, M. et al. Identification and functional analysis of mutations in FAD-binding domain of mitochondrial glycerophosphate dehydrogenase in caucasian patients with type 2 diabetes mellitus. Endocrine 16, 39–42 (2001).
pubmed: 11822825
doi: 10.1385/ENDO:16:1:39
Fabregat, M. E. et al. Enzyme-linked immunosorbent assay of autoantibodies against mitochondrial glycerophosphate dehydrogenase in insulin-dependent and non-insulin-dependent diabetic subjects. Biochem. Mol. Med. 62, 172–177 (1997).
pubmed: 9441869
doi: 10.1006/bmme.1997.2642
Fabregat, M. E. et al. Autoantibodies against mitochondrial glycerophosphate dehydrogenase in patients with IDDM. Diabetes Res. Clin. Pract. 38, 115–121 (1997).
pubmed: 9483375
doi: 10.1016/S0168-8227(97)00095-8
Juaristi, I. et al. ARALAR/AGC1 deficiency, a neurodevelopmental disorder with severe impairment of neuronal mitochondrial respiration, does not produce a primary increase in brain lactate. J. Neurochem. 142, 132–139 (2017).
pubmed: 28429368
doi: 10.1111/jnc.14047
Bianchi, M. C., Sgandurra, G., Tosetti, M., Battini, R. & Cioni, G. Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies. Biosci. Rep. 27, 69–85 (2007).
pubmed: 17510789
doi: 10.1007/s10540-007-9046-z
Finsterer, J. Leigh and Leigh-like syndrome in children and adults. Pediatr. Neurol. 39, 223–235 (2008).
pubmed: 18805359
doi: 10.1016/j.pediatrneurol.2008.07.013
Haas, R. H. et al. The in-depth evaluation of suspected mitochondrial disease. Mol. Genet. Metab. 94, 16–37 (2008).
pubmed: 18243024
pmcid: 2810849
doi: 10.1016/j.ymgme.2007.11.018
Nguyen, N. H. T., Brathe, A. & Hassel, B. Neuronal uptake and metabolism of glycerol and the neuronal expression of mitochondrial glycerol-3-phosphate dehydrogenase. J. Neurochem. 85, 831–842 (2003).
pubmed: 12716415
doi: 10.1046/j.1471-4159.2003.01762.x
Leveille, P. J., McGinnis, J. F., Maxwell, D. S. & de Vellis, J. Immunocytochemical localization of glycerol-3-phosphate dehydrogenase in rat oligodendrocytes. Brain Res. 196, 287–305 (1980).
pubmed: 6772276
doi: 10.1016/0006-8993(80)90397-2
Montz, H. P., Althaus, H. H., Gebicke-Haerter, P. J. & Neuhoff, V. Glycerol phosphate dehydrogenase activity of oligodendrocytes isolated from adult pig brain: its inducibility by hydrocortisone. J. Neurochem. 45, 1201–1204 (1985).
pubmed: 4031885
doi: 10.1111/j.1471-4159.1985.tb05542.x
Giulivi, C., Wang, J. Y. & Hagerman, R. J. Artificial neural network applied to fragile X-associated tremor/ataxia syndrome stage diagnosis based on peripheral mitochondrial bioenergetics and brain imaging outcomes. Sci. Rep. 12, 21382 (2022).
pubmed: 36496525
pmcid: 9741636
doi: 10.1038/s41598-022-25615-2
Li, W. et al. Metformin alters locomotor and cognitive function and brain metabolism in normoglycemic mice. Aging Dis. 10, 949–963 (2019).
pubmed: 31595194
pmcid: 6764722
doi: 10.14336/AD.2019.0120
Votyakova, T. V. & Reynolds, I. J. DeltaPsi(m)-Dependent and -independent production of reactive oxygen species by rat brain mitochondria. J. Neurochem. 79, 266–277 (2001).
pubmed: 11677254
doi: 10.1046/j.1471-4159.2001.00548.x
Chavda, V. & Lu, B. Reverse electron transport at mitochondrial complex I in ischemic stroke, aging, and age-related diseases. Antioxidants 12, 895 (2023).
pubmed: 37107270
pmcid: 10135819
doi: 10.3390/antiox12040895
Barrientos, A. & Moraes, C. T. Titrating the effects of mitochondrial complex I impairment in the cell physiology. J. Biol. Chem. 274, 16188–16197 (1999).
pubmed: 10347173
doi: 10.1074/jbc.274.23.16188
Kaminski, M. M. et al. T cell activation is driven by an ADP-dependent glucokinase linking enhanced glycolysis with mitochondrial reactive oxygen species generation. Cell Rep. 2, 1300–1315 (2012).
pubmed: 23168256
doi: 10.1016/j.celrep.2012.10.009
Langston, P. K. et al. Glycerol phosphate shuttle enzyme GPD2 regulates macrophage inflammatory responses. Nat. Immunol. 20, 1186–1195 (2019).
pubmed: 31384058
pmcid: 6707851
doi: 10.1038/s41590-019-0453-7
Mracek, T., Pecinova, A., Vrbacky, M., Drahota, Z. & Houstek, J. High efficiency of ROS production by glycerophosphate dehydrogenase in mammalian mitochondria. Arch. Biochem. Biophys. 481, 30–36 (2009).
pubmed: 18952046
doi: 10.1016/j.abb.2008.10.011
Kota, V., Dhople, V. M. & Shivaji, S. Tyrosine phosphoproteome of hamster spermatozoa: role of glycerol-3-phosphate dehydrogenase 2 in sperm capacitation. Proteomics9, 1809–1826 (2009).
pubmed: 19333995
doi: 10.1002/pmic.200800519
Kota, V. et al. Role of glycerol-3-phosphate dehydrogenase 2 in mouse sperm capacitation. Mol. Reprod. Dev. 77, 773–783 (2010).
pubmed: 20602492
doi: 10.1002/mrd.21218
Swierczyński, J., Scislowski, P. & Aleksandrowicz, Z. High activity of alpha-glycerophosphate oxidation by human placental mitochondria. Biochim. Biophys. Acta 429, 46–54 (1976).
pubmed: 816383
doi: 10.1016/0005-2744(76)90028-0
Olivera, A. A. & Meigs, R. A. Mitochondria from human term placenta. II. Characterization of respiratory pathways and coupling mechanisms. Biochim. Biophys. Acta 376, 436–445 (1975).
pubmed: 47760
doi: 10.1016/0005-2728(75)90165-6
Honzík, T. et al. Specific properties of heavy fraction of mitochondria from human-term placenta—glycerophosphate-dependent hydrogen peroxide production. Placenta 27, 348–356 (2006).
pubmed: 15949844
doi: 10.1016/j.placenta.2005.03.010
Algoet, M. et al. Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc. Med. 33, 357–366 (2023).
pubmed: 35181472
doi: 10.1016/j.tcm.2022.02.005
Song, R., Dasgupta, C., Mulder, C. & Zhang, L. MicroRNA-210 controls mitochondrial metabolism and protects heart function in myocardial infarction. Circulation 145, 1140–1153 (2022).
pubmed: 35296158
pmcid: 9007902
doi: 10.1161/CIRCULATIONAHA.121.056929
Ishihama, S. et al. LPL/AQP7/GPD2 promotes glycerol metabolism under hypoxia and prevents cardiac dysfunction during ischemia. FASEB J. 35, e22048 (2021).
pubmed: 34807469
doi: 10.1096/fj.202100882R
Qu, H. et al. Deficiency of mitochondrial glycerol 3-phosphate dehydrogenase exacerbates podocyte injury and the progression of diabetic kidney disease. Diabetes 70, 1372–1387 (2021).
pubmed: 33741719
doi: 10.2337/db20-1157
Saheki, T. et al. Citrin/mitochondrial glycerol-3-phosphate dehydrogenase double knock-out mice recapitulate features of human citrin deficiency. J. Biol. Chem. 282, 25041–25052 (2007).
pubmed: 17591776
doi: 10.1074/jbc.M702031200
Saheki, T. et al. Metabolomic analysis reveals hepatic metabolite perturbations in citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mice, a model of human citrin deficiency. Mol. Genet. Metab. 104, 492–500 (2011).
pubmed: 21908222
doi: 10.1016/j.ymgme.2011.08.015
Sinasac, D. S. et al. Slc25a13-knockout mice harbor metabolic deficits but fail to display hallmarks of adult-onset type II citrullinemia. Mol. Cell Biol. 24, 527–536 (2004).
pubmed: 14701727
pmcid: 343808
doi: 10.1128/MCB.24.2.527-536.2004
Moriyama, M. et al. Mechanism for increased hepatic glycerol synthesis in the citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mouse: Urine glycerol and glycerol 3-phosphate as potential diagnostic markers of human citrin deficiency. Biochim. Biophys. Acta 1852, 1787–1795 (2015).
pubmed: 25952905
doi: 10.1016/j.bbadis.2015.04.023
Daoud, H. et al. Haploinsufficiency of the GPD2 gene in a patient with nonsyndromic mental retardation. Hum. Genet. 124, 649–658 (2009).
pubmed: 19011903
doi: 10.1007/s00439-008-0588-3
Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31–46 (2022).
pubmed: 35022204
doi: 10.1158/2159-8290.CD-21-1059
Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
pubmed: 21376230
doi: 10.1016/j.cell.2011.02.013
Finley, L. W. S. What is cancer metabolism? Cell 186, 1670–1688 (2023).
pubmed: 36858045
doi: 10.1016/j.cell.2023.01.038
Faubert, B., Solmonson, A. & DeBerardinis, R. J. Metabolic reprogramming and cancer progression. Science 368, eaaw5473 (2020).
pubmed: 32273439
pmcid: 7227780
doi: 10.1126/science.aaw5473
DeBerardinis, R. J. & Chandel, N. S. Fundamentals of cancer metabolism. Sci. Adv. 2, e1600200 (2016).
pubmed: 27386546
pmcid: 4928883
doi: 10.1126/sciadv.1600200
Mossmann, D., Park, S. & Hall, M. N. mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat. Rev. Cancer 18, 744–757 (2018).
pubmed: 30425336
doi: 10.1038/s41568-018-0074-8
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L. & Dang, C. V. MYC, metabolism, and cancer. Cancer Discov. 5, 1024–1039 (2015).
pubmed: 26382145
pmcid: 4592441
doi: 10.1158/2159-8290.CD-15-0507
Hay, N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat. Rev. Cancer 16, 635–649 (2016).
pubmed: 27634447
pmcid: 5516800
doi: 10.1038/nrc.2016.77
Munir, R., Lisec, J., Swinnen, J. V. & Zaidi, N. Lipid metabolism in cancer cells under metabolic stress. Br. J. Cancer 120, 1090–1098 (2019).
pubmed: 31092908
pmcid: 6738079
doi: 10.1038/s41416-019-0451-4
Kwon, H., Oh, S., Jin, X., An, Y. J. & Park, S. Cancer metabolomics in basic science perspective. Arch. Pharm. Res. 38, 372–380 (2015).
pubmed: 25630795
doi: 10.1007/s12272-015-0552-4
Yao, C. H. et al. Uncoupled glycerol-3-phosphate shuttle in kidney cancer reveals that cytosolic GPD is essential to support lipid synthesis. Mol. Cell 83, 1340–1349.e1347 (2023).
pubmed: 37084714
doi: 10.1016/j.molcel.2023.03.023
Shonk, C. E., Arison, R. N., Koven, B. J., Majima, H. & Boxer, G. E. Enzyme patterns in human tissues. 3. Glycolytic enzymes in normal and malignant tissues of the colon and rectum. Cancer Res. 25, 206–213 (1965).
pubmed: 14264053
Zhou, C. F. et al. Identification of glycerol-3-phosphate dehydrogenase 1 as a tumour suppressor in human breast cancer. Oncotarget 8, 101309–101324 (2017).
pubmed: 29254166
pmcid: 5731876
doi: 10.18632/oncotarget.21087
Zhang, W. et al. Allosteric activation of the metabolic enzyme GPD1 inhibits bladder cancer growth via the lysoPC-PAFR-TRPV2 axis. J. Hematol. Oncol. 15, 93 (2022).
pubmed: 35836291
pmcid: 9284842
doi: 10.1186/s13045-022-01312-5
Yoneten, K. K. et al. Comparative proteome analysis of breast cancer tissues highlights the importance of glycerol-3-phosphate dehydrogenase 1 and monoacylglycerol lipase in breast cancer metabolism. Cancer Genom. Proteom. 16, 377–397 (2019).
doi: 10.21873/cgp.20143
Karaosmanoglu Yoneten, K., Kasap, M., Arga, K. Y., Akpinar, G. & Utkan, N. Z. Decreased serum levels of glycerol-3- phosphate dehydrogenase 1 and monoacylglycerol lipase act as diagnostic biomarkers for breast cancer. Cancer Biomark. 34, 67–76 (2022).
pubmed: 34657876
doi: 10.3233/CBM-203093
Sanchez, D. J. & Simon, M. C. Genetic and metabolic hallmarks of clear cell renal cell carcinoma. Biochim. Biophys. Acta Rev. Cancer 1870, 23–31 (2018).
pubmed: 29959988
pmcid: 6561085
doi: 10.1016/j.bbcan.2018.06.003
Hakimi, A. A. et al. An integrated metabolic atlas of clear cell renal cell carcinoma. Cancer Cell 29, 104–116 (2016).
pubmed: 26766592
pmcid: 4809063
doi: 10.1016/j.ccell.2015.12.004
Nguyen, T. T. M. et al. GPX8 regulates clear cell renal cell carcinoma tumorigenesis through promoting lipogenesis by NNMT. J. Exp. Clin. Cancer Res. 42, 42 (2023).
pubmed: 36750850
pmcid: 9903620
doi: 10.1186/s13046-023-02607-2
Rusu, P. et al. GPD1 specifically marks dormant glioma stem cells with a distinct metabolic profile. Cell Stem Cell 25, 241–257.e248 (2019).
pubmed: 31303549
doi: 10.1016/j.stem.2019.06.004
Turyn, J. et al. Increased activity of glycerol 3-phosphate dehydrogenase and other lipogenic enzymes in human bladder cancer. Horm. Metab. Res. 35, 565–569 (2003).
pubmed: 14605988
doi: 10.1055/s-2003-43500
Xie, J. et al. GPD1 enhances the anticancer effects of metformin by synergistically increasing total cellular glycerol-3-phosphate. Cancer Res. 80, 2150–2162 (2020).
pubmed: 32179514
doi: 10.1158/0008-5472.CAN-19-2852
Petan, T. Lipid droplets in cancer. Rev. Physiol. Biochem. Pharm. 185, 53–86 (2020).
doi: 10.1007/112_2020_51
Wettersten, H. I. Reprogramming of metabolism in kidney cancer. Semin. Nephrol. 40, 2–13 (2020).
pubmed: 32130963
doi: 10.1016/j.semnephrol.2019.12.002
Tan, S. K. & Welford, S. M. Lipid in renal carcinoma: queen bee to target? Trends Cancer 6, 448–450 (2020).
pubmed: 32459999
doi: 10.1016/j.trecan.2020.02.017
Hsieh, J. J. et al. Renal cell carcinoma. Nat. Rev. Dis. Prim. 3, 17009 (2017).
pubmed: 28276433
doi: 10.1038/nrdp.2017.9
Hunt, S. M., Osnos, M. & Rivlin, R. S. Thyroid hormone regulation of mitochondrial α-glycerophosphate dehydrogenase in liver and hepatoma. Cancer Res. 30, 1764–1768 (1970).
pubmed: 4318703
Chowdhury, S. K., Gemin, A. & Singh, G. High activity of mitochondrial glycerophosphate dehydrogenase and glycerophosphate-dependent ROS production in prostate cancer cell lines. Biochem. Biophys. Res. Commun. 333, 1139–1145 (2005).
pubmed: 15967408
doi: 10.1016/j.bbrc.2005.06.017
Chowdhury, S. K., Raha, S., Tarnopolsky, M. A. & Singh, G. Increased expression of mitochondrial glycerophosphate dehydrogenase and antioxidant enzymes in prostate cancer cell lines/cancer. Free Radic. Res. 41, 1116–1124 (2007).
pubmed: 17886033
doi: 10.1080/10715760701579314
Yuan, L. et al. Switching off IMMP2L signaling drives senescence via simultaneous metabolic alteration and blockage of cell death. Cell Res. 28, 625–643 (2018).
pubmed: 29808012
pmcid: 5993829
doi: 10.1038/s41422-018-0043-5
Kaplon, J. et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 498, 109–112 (2013).
pubmed: 23685455
doi: 10.1038/nature12154
Thakur, S. et al. Metformin targets mitochondrial glycerophosphate dehydrogenase to control rate of oxidative phosphorylation and growth of thyroid cancer in vitro and in vivo. Clin. Cancer Res. 24, 4030–4043 (2018).
pubmed: 29691295
pmcid: 6095745
doi: 10.1158/1078-0432.CCR-17-3167
Mikeli, M. et al. Contribution of GPD2/mGPDH to an alternative respiratory chain of the mitochondrial energy metabolism and the stemness in CD133-positive HuH-7 cells. Genes Cells 25, 139–148 (2020).
pubmed: 31887237
doi: 10.1111/gtc.12744
Suetsugu, A. et al. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem. Biophys. Res. Commun. 351, 820–824 (2006).
pubmed: 17097610
doi: 10.1016/j.bbrc.2006.10.128
Mikeli, M., Fujikawa, M. & Tanabe, T. GPD2: the relationship with cancer and neural stemness. Cells Dev. 173, 203824 (2023).
pubmed: 36592694
doi: 10.1016/j.cdev.2022.203824
Oh, S. et al. Non-bioenergetic roles of mitochondrial GPD2 promote tumor progression. Theranostics 13, 438–457 (2023).
pubmed: 36632231
pmcid: 9830446
doi: 10.7150/thno.75973
Li, X. et al. mGPDH deficiency leads to melanoma metastasis via induced NRF2. J. Cell Mol. Med. 25, 5305–5315 (2021).
pubmed: 33939274
pmcid: 8178277
doi: 10.1111/jcmm.16542
Gallorini, M., Carradori, S., Panieri, E., Sova, M. & Saso, L. Modulation of NRF2: biological dualism in cancer, targets and possible therapeutic applications. Antioxid. Redox Signal. https://doi.org/10.1089/ars.2022.0213 (2023).
Reuter, S., Gupta, S. C., Chaturvedi, M. M. & Aggarwal, B. B. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic. Biol. Med. 49, 1603–1616 (2010).
pubmed: 20840865
pmcid: 2990475
doi: 10.1016/j.freeradbiomed.2010.09.006
Sabharwal, S. S. & Schumacker, P. T. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles’ heel? Nat. Rev. Cancer 14, 709–721 (2014).
pubmed: 25342630
pmcid: 4657553
doi: 10.1038/nrc3803
Hayes, J. D., Dinkova-Kostova, A. T. & Tew, K. D. Oxidative stress in cancer. Cancer Cell 38, 167–197 (2020).
pubmed: 32649885
pmcid: 7439808
doi: 10.1016/j.ccell.2020.06.001
Orr, A. L., Quinlan, C. L., Perevoshchikova, I. V. & Brand, M. D. A refined analysis of superoxide production by mitochondrial sn-glycerol 3-phosphate dehydrogenase. J. Biol. Chem. 287, 42921–42935 (2012).
pubmed: 23124204
pmcid: 3522288
doi: 10.1074/jbc.M112.397828
Wong, H. S., Dighe, P. A., Mezera, V., Monternier, P. A. & Brand, M. D. Production of superoxide and hydrogen peroxide from specific mitochondrial sites under different bioenergetic conditions. J. Biol. Chem. 292, 16804–16809 (2017).
pubmed: 28842493
pmcid: 5641882
doi: 10.1074/jbc.R117.789271
Mracek, T. et al. ROS generation and multiple forms of mammalian mitochondrial glycerol-3-phosphate dehydrogenase. Biochim. Biophys. Acta 1837, 98–111 (2014).
pubmed: 23999537
doi: 10.1016/j.bbabio.2013.08.007
Dueregger, A. et al. Differential utilization of dietary fatty acids in benign and malignant cells of the prostate. PLoS One 10, e0135704 (2015).
pubmed: 26285134
pmcid: 4540467
doi: 10.1371/journal.pone.0135704
Beyoglu, D. et al. Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification. Hepatology 58, 229–238 (2013).
pubmed: 23463346
doi: 10.1002/hep.26350
Lorenzetti, F., Capiglioni, A. M., Marinelli, R. A., Carrillo, M. C. & Alvarez, M. L. Hepatic glycerol metabolism is early reprogrammed in rat liver cancer development. Biochimie 170, 88–93 (2020).
pubmed: 31923480
doi: 10.1016/j.biochi.2020.01.002
Madiraju, A. K. et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510, 542–546 (2014).
pubmed: 24847880
pmcid: 4074244
doi: 10.1038/nature13270
Madiraju, A. K. et al. Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. Nat. Med. 24, 1384–1394 (2018).
pubmed: 30038219
pmcid: 6129196
doi: 10.1038/s41591-018-0125-4
Mallik, R. & Chowdhury, T. A. Metformin in cancer. Diabetes Res Clin. Pract. 143, 409–419 (2018).
pubmed: 29807101
doi: 10.1016/j.diabres.2018.05.023
Hua, Y. et al. Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing. J. Transl. Med. 21, 403 (2023).
pubmed: 37344841
pmcid: 10286395
doi: 10.1186/s12967-023-04263-8
Bell, R. M. & Coleman, R. A. Enzymes of glycerolipid synthesis in eukaryotes. Annu. Rev. Biochem. 49, 459–487 (1980).
pubmed: 6250446
doi: 10.1146/annurev.bi.49.070180.002331
Yu, J. et al. Update on glycerol-3-phosphate acyltransferases: the roles in the development of insulin resistance. Nutr. Diabetes 8, 34 (2018).
pubmed: 29799006
pmcid: 5968029
doi: 10.1038/s41387-018-0045-x
Hajra, A. K. Dihydroxyacetone phosphate acyltransferase. Biochim. Biophys. Acta 1348, 27–34 (1997).
pubmed: 9370313
doi: 10.1016/S0005-2760(97)00120-3
Brites, P., Waterham, H. R. & Wanders, R. J. Functions and biosynthesis of plasmalogens in health and disease. Biochim. Biophys. Acta 1636, 219–231 (2004).
pubmed: 15164770
doi: 10.1016/j.bbalip.2003.12.010
Jiménez-Rojo, N. & Riezman, H. On the road to unraveling the molecular functions of ether lipids. FEBS Lett. 593, 2378–2389 (2019).
pubmed: 31166014
doi: 10.1002/1873-3468.13465
Wu, S. et al. A ferroptosis defense mechanism mediated by glycerol-3-phosphate dehydrogenase 2 in mitochondria. Proc. Natl Acad. Sci. USA 119, e2121987119 (2022).
pubmed: 35749365
pmcid: 9245637
doi: 10.1073/pnas.2121987119
Richard, A. J., Hang, H. & Stephens, J. M. Pyruvate dehydrogenase complex (PDC) subunits moonlight as interaction partners of phosphorylated STAT5 in adipocytes and adipose tissue. J. Biol. Chem. 292, 19733–19742 (2017).
pubmed: 28982698
pmcid: 5712614
doi: 10.1074/jbc.M117.811794
Shegay, P. V., Shatova, O. P., Zabolotneva, A. A., Shestopalov, A. V. & Kaprin, A. D. Moonlight functions of glycolytic enzymes in cancer. Front. Mol. Biosci. 10, 1076138 (2023).
pubmed: 37449059
pmcid: 10337784
doi: 10.3389/fmolb.2023.1076138
Castello, A., Hentze, M. W. & Preiss, T. Metabolic enzymes enjoying new partnerships as RNA-binding proteins. Trends Endocrinol. Metab. 26, 746–757 (2015).
pubmed: 26520658
pmcid: 4671484
doi: 10.1016/j.tem.2015.09.012
Bajzikova, M. et al. Reactivation of dihydroorotate dehydrogenase-driven pyrimidine biosynthesis restores tumor growth of respiration-deficient cancer cells. Cell Metab. 29, 399–416.e310 (2019).
pubmed: 30449682
doi: 10.1016/j.cmet.2018.10.014
Mao, C. et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature 593, 586–590 (2021).
pubmed: 33981038
pmcid: 8895686
doi: 10.1038/s41586-021-03539-7
Orr, A. L. et al. Novel inhibitors of mitochondrial sn-glycerol 3-phosphate dehydrogenase. PLoS One 9, e89938 (2014).
pubmed: 24587137
pmcid: 3933693
doi: 10.1371/journal.pone.0089938
Singh, G. Mitochondrial FAD-linked glycerol-3-phosphate dehydrogenase: a target for cancer therapeutics. Pharmaceuticals 7, 192–206 (2014).
pubmed: 24521925
pmcid: 3942692
doi: 10.3390/ph7020192
Lee, J. et al. Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism. Nature 568, 254–258 (2019).
pubmed: 30842661
pmcid: 6698916
doi: 10.1038/s41586-019-1005-x
Owen, M. R., Doran, E. & Halestrap, A. P. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 348, 607–614 (2000).
pubmed: 10839993
pmcid: 1221104
doi: 10.1042/bj3480607
Ashton, T. M., McKenna, W. G., Kunz-Schughart, L. A. & Higgins, G. S. Oxidative phosphorylation as an emerging target in cancer therapy. Clin. Cancer Res. 24, 2482–2490 (2018).
pubmed: 29420223
doi: 10.1158/1078-0432.CCR-17-3070
Rauchová, H., Vokurková, M. & Drahota, Z. Inhibition of mitochondrial glycerol-3-phosphate dehydrogenase by α-tocopheryl succinate. Int. J. Biochem. Cell Biol. 53, 409–413 (2014).
pubmed: 24953557
doi: 10.1016/j.biocel.2014.06.010
Wang, C., Zhou, Q. & Wu, S. T. Scopolin obtained from Smilax china L. against hepatocellular carcinoma by inhibiting glycolysis: a network pharmacology and experimental study. J. Ethnopharmacol. 296, 115469 (2022).
pubmed: 35718053
doi: 10.1016/j.jep.2022.115469
Zhao, Y., Zhang, L., Guo, M. & Yang, H. Taraxasterol suppresses cell proliferation and boosts cell apoptosis via inhibiting GPD2-mediated glycolysis in gastric cancer. Cytotechnology 73, 815–825 (2021).
pubmed: 34776631
pmcid: 8554918
doi: 10.1007/s10616-021-00499-8
Wu, S. T. et al. Esculetin inhibits cancer cell glycolysis by binding tumor PGK2, GPD2, and GPI. Front. Pharm. 11, 379 (2020).
doi: 10.3389/fphar.2020.00379
Orozco, J. M. et al. Dihydroxyacetone phosphate signals glucose availability to mTORC1. Nat. Metab. 2, 893–901 (2020).
pubmed: 32719541
pmcid: 7995735
doi: 10.1038/s42255-020-0250-5
Berrada, W., Naya, A., Ouafik, L. & Bourhim, N. Effect of hibernation, thyroid hormones and dexamethasone on cytosolic and mitochondrial glycerol-3-phosphate dehydrogenase from jerboa (Jaculus orientalis). Comp. Biochem. Physiol. B Biochem. Mol. Biol. 125, 439–449 (2000).
pubmed: 10904857
doi: 10.1016/S0305-0491(00)00161-9